PCM Trials WP 2
Clinics ration supplies as cancer drug shortages proliferate
While drug shortages have been a major cause for concern over the past few years, medications to treat cancer are in particularly short supply.
Pfizer’s Ngenla finally secures FDA approval following a rocky road to market
Pfizer takes on haemophilia B gene therapy market with new FDA application
Rystiggo receives FDA approval, strengthening UCB’s myasthenia gravis portfolio
Inflation reduction act boosts biologic drug venture financing over small molecules
Amgen secures full FDA approval for leukaemia therapy Blincyto
